Press Releases
- Sarepta Therapeutics Names Louise Rodino-Klapac, Ph.D., Head of Research and Development11/17/2021
- Sarepta Therapeutics Appoints Stephen L. Mayo, Ph.D., to its Board of Directors11/17/2021
- Sarepta Therapeutics Announces Third Quarter 2021 Financial Results and Recent Corporate Developments11/03/2021
News Features
Media Library
Press Contact
Tracy Sorrentino
Executive Director, Public Relations
Sarepta Therapeutics, Inc.
[email protected]
617-274-4052